This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Cardiovascular
Use of complementary medicine common in patients with diabetes
Read more
Intermediate and standard-dose prophylactic anticoagulation in COVID-19 equivalent
Read more
Use of advanced machine learning models does not appear to improve post-MI mortality risk prediction
Read more
Single vs serial troponin measurements equally effective in acute coronary syndrome
Read more
Risk of adverse cardiovascular events by adding newer diabetes drugs to insulin therapy
Read more
Prior statin use associated with lower mortality in COVID-19
Read more
Detection of atrial fibrillation in older people feasible by using wearable device
Read more
Is ischaemic heart disease induced by severe COVID-19?
Read more
Report calls for urgent action on heart failure
Read more
Higher mortality linked to greater intake of eggs and cholesterol-rich food
Read more
Significant weight loss achieved by semaglutide in obese patients without diabetes
Read more
Prediabetes in older adults not prognostic for type 2 diabetes
Read more
Bimagrumab leads to significant fat loss in obese, type 2 diabetic patients
Read more
Metformin use in diabetes protective against COVID-19-related mortality
Read more
Low levels of alcohol intake linked to greater risk of atrial fibrillation
Read more
Making physical activity more vigorous reduces all-cause mortality
Read more
Statins reduce cardiac events in adults aged 50-75 after only 2.5 years
Read more
Page 20 of 39
« First
«
...
10
...
18
19
20
21
22
...
30
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: